(Q40405968)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16013192%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Suboptimal intensity of risk factor modification in PAD (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16013192%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16013192%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Andrzej Szuba

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16013192%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Roberta K Oka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16013192%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Eva Umoh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16013192%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

John C Giacomini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16013192%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16013192%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16013192%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16013192%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16013192%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

91-96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16013192%20AND%20SRC:MED&resulttype=core&format=json

Current medical therapies for patients with peripheral arterial disease: a critical review

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Peripheral arterial disease detection, awareness, and treatment in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Clinical practice. Initial management of glycemia in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Prevalence and clinical implications of American Diabetes Association-defined diabetes and other categories of glucose dysregulation in older adults: the health, aging and body composition study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Glucose tolerance and the risk of cardiovascular disease: the Zutphen Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Peripheral arterial disease: medical care and prevention of complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Management of intermittent claudication: the importance of secondary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Risk factors associated with the development of peripheral arterial disease in smokers: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Exercise training for claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA

Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X05VM611OA